+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibodies Contract Manufacturing Market - Global Forecast 2025-2030- Product Image
Antibodies Contract Manufacturing Market - Global Forecast 2025-2030- Product Image
Sale

Antibodies Contract Manufacturing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715633
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antibodies contract manufacturing market is evolving as biopharmaceutical companies increasingly look to external partners to address growing development complexities, accelerate timelines, and manage costs in the race for innovative therapies. Strategic outsourcing and process optimization are central to maintaining competitiveness as demand for biologics rises and regulatory expectations advance.

Market Snapshot: Antibodies Contract Manufacturing Market Overview

The Antibodies Contract Manufacturing Market grew from USD 18.04 billion in 2024 to USD 20.05 billion in 2025. It is expected to continue growing at a CAGR of 10.91%, reaching USD 33.60 billion by 2030. This sustained expansion reflects organizations' increased reliance on external manufacturing partners to reduce capital expenditures, enhance responsiveness, and aid advanced therapy launches in a highly regulated environment.

Scope & Segmentation: Comprehensive View for Decision-Makers

  • Process Stages: Upstream bioreactor operation and cell line development, media and feed preparation, and downstream purification including hydrophobic interaction, ion exchange, and Protein A chromatography.
  • Filtration Strategies: Filtration, centrifugation, ultrafiltration, and diafiltration steps crucial for process clarity and concentration.
  • Geographic Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Technology Investments: State-of-the-art single-use bioreactors, advanced chromatography platforms, continuous manufacturing, digitalization tools, and integrated data management are driving differentiation.
  • Company Profiles: Coverage of strategic initiatives and recent developments across Lonza Group Ltd, Samsung Biologics Co., Ltd, WuXi Biologics (Hong Kong) Co., Ltd, Catalent, Inc., Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies US, LLC, Merck KGaA, AGC Biologics Inc, Thermo Fisher Scientific Inc., and Rentschler Biopharma SE.

Key Takeaways: Strategic Insights for Senior Leaders

  • Contract manufacturing organizations (CMOs and CDMOs) are rapidly expanding capabilities to address the increasingly complex antibody modalities, such as bispecifics, through modular manufacturing suites and flexible technologies.
  • Digital transformation—including real-time analytics and predictive modeling—is enhancing yield consistency and enabling faster response to process deviations.
  • Partnerships, including joint ventures with technology providers and collaborations with academic institutions, are central to innovation in upstream and downstream operations.
  • Regional differentiation shapes market strategies: North America offers regulatory expertise and rapid validation cycles; Europe, Middle East & Africa focus on sustainability and regulatory diversity; Asia-Pacific leverages cost efficiency and capacity expansion enabled by government incentives.
  • Enhanced supply chain agility—driven by multi-sourcing and nearshoring—protects operational resilience during geopolitical changes and demand fluctuations.

Tariff Impact: Navigating United States Trade Policy Changes

The introduction of elevated tariffs in the United States in 2025 has directly influenced manufacturing costs and sourcing dynamics for raw materials and specialized filtration and chromatography supplies. Companies have responded by diversifying supplier bases, investing in domestic alliances, and optimizing facility footprints to reduce tariff exposure and operational risk.

Methodology & Data Sources

This report draws on structured interviews with senior executives (across contract manufacturing, drug development, and regulatory affairs), combined with peer-reviewed literature, patent data, regulatory guidance, and anonymized industry analytics. Triangulation and expert review of findings ensure currency and credibility of the insights.

Why This Report Matters

  • Empowers decision-makers to benchmark operational models, technology adoption, and partnership strategies against industry leaders.
  • Supports the formulation of supply chain, investment, and site selection strategies that align with current and evolving regulatory and economic environments.

Conclusion

Continuous investment in technology, flexible manufacturing, and partnership models are reshaping the antibodies contract manufacturing landscape. Organizations that prioritize agile supply chains and digital transformation will be best positioned for long-term growth and sustained competitiveness.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning in antibody process analytics to enhance manufacturing efficiency
5.2. Adoption of single use bioreactor systems for flexible and scalable monoclonal antibody production
5.3. Implementation of continuous biomanufacturing platforms to reduce costs and accelerate antibody CMO timelines
5.4. Advanced host cell line engineering drives higher monoclonal antibody titers and process consistency
5.5. Regulatory harmonization initiatives facilitating global antibody contract manufacturing approval pathways
5.6. Emergence of biosimilar antibody CMC service offerings to meet rising demand for cost effective biologics
5.7. Integration of digital twin modeling and real time monitoring to optimize antibody manufacturing processes
5.8. Expansion of personalized immunotherapy antibody manufacturing to support niche oncology and autoimmune treatments
5.9. Implementation of sustainable green manufacturing practices to reduce environmental impact in antibody CMOs
5.10. Adoption of high throughput screening platforms to accelerate antibody candidate selection and development pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibodies Contract Manufacturing Market, by Downstream
8.1. Introduction
8.2. Chromatography Purification
8.2.1. Hydrophobic Interaction Chromatography
8.2.2. Ion Exchange Chromatography
8.2.3. Protein A Chromatography
8.3. Filtration And Centrifugation
8.4. Ultrafiltration And Diafiltration
8.5. Upstream
8.5.1. Bioreactor Operation
8.5.2. Cell Line Development
8.5.3. Media And Feed Preparation
9. Americas Antibodies Contract Manufacturing Market
9.1. Introduction
9.2. United States
9.3. Canada
9.4. Mexico
9.5. Brazil
9.6. Argentina
10. Europe, Middle East & Africa Antibodies Contract Manufacturing Market
10.1. Introduction
10.2. United Kingdom
10.3. Germany
10.4. France
10.5. Russia
10.6. Italy
10.7. Spain
10.8. United Arab Emirates
10.9. Saudi Arabia
10.10. South Africa
10.11. Denmark
10.12. Netherlands
10.13. Qatar
10.14. Finland
10.15. Sweden
10.16. Nigeria
10.17. Egypt
10.18. Turkey
10.19. Israel
10.20. Norway
10.21. Poland
10.22. Switzerland
11. Asia-Pacific Antibodies Contract Manufacturing Market
11.1. Introduction
11.2. China
11.3. India
11.4. Japan
11.5. Australia
11.6. South Korea
11.7. Indonesia
11.8. Thailand
11.9. Philippines
11.10. Malaysia
11.11. Singapore
11.12. Vietnam
11.13. Taiwan
12. Competitive Landscape
12.1. Market Share Analysis, 2024
12.2. FPNV Positioning Matrix, 2024
12.3. Competitive Analysis
12.3.1. Lonza Group Ltd
12.3.2. Samsung Biologics Co., Ltd
12.3.3. WuXi Biologics (Hong Kong) Co., Ltd
12.3.4. Catalent, Inc.
12.3.5. Boehringer Ingelheim International GmbH
12.3.6. Fujifilm Diosynth Biotechnologies US, LLC
12.3.7. Merck KGaA
12.3.8. AGC Biologics Inc
12.3.9. Thermo Fisher Scientific Inc.
12.3.10. Rentschler Biopharma SE
13. ResearchAI
14. ResearchStatistics
15. ResearchContacts
16. ResearchArticles
17. Appendix
List of Figures
FIGURE 1. ANTIBODIES CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 8. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 10. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. ANTIBODIES CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 16. ANTIBODIES CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 17. ANTIBODIES CONTRACT MANUFACTURING MARKET: RESEARCHAI
FIGURE 18. ANTIBODIES CONTRACT MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 19. ANTIBODIES CONTRACT MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 20. ANTIBODIES CONTRACT MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIBODIES CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY PROTEIN A CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY PROTEIN A CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY FILTRATION AND CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY FILTRATION AND CENTRIFUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION AND DIAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION AND DIAFILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY MEDIA AND FEED PREPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY MEDIA AND FEED PREPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 35. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 36. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 43. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 44. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 45. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 46. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 51. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 52. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 53. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 54. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 55. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 56. CANADA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 57. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 58. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 59. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 60. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 61. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 62. MEXICO ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 63. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 64. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 65. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 66. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 67. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 68. BRAZIL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 69. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 70. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 71. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 72. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 73. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 74. ARGENTINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 84. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 88. UNITED KINGDOM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 89. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 90. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 91. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 92. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 93. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 94. GERMANY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 95. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 96. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 97. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 98. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 99. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 100. FRANCE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 101. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 102. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 103. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 104. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 105. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 106. RUSSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 107. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 108. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 109. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 110. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 111. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 112. ITALY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 113. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 114. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 115. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 116. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 117. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 118. SPAIN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 126. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 128. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 130. SAUDI ARABIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 132. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 134. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 136. SOUTH AFRICA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 137. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 138. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 139. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 140. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 141. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 142. DENMARK ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 143. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 144. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 145. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 146. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 147. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 148. NETHERLANDS ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 149. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 150. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 151. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 152. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 153. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 154. QATAR ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 155. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 156. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 157. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 158. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 159. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 160. FINLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 161. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 162. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 163. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 164. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 165. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 166. SWEDEN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 167. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 168. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 169. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 170. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 171. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 172. NIGERIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 173. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 174. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 175. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 176. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 177. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 178. EGYPT ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 179. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 180. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 181. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 182. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 183. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 184. TURKEY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 185. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 186. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 187. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 188. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 189. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 190. ISRAEL ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 191. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 192. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 193. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 194. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 195. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 196. NORWAY ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 197. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 198. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 199. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 200. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 201. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 202. POLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 203. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 204. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 205. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 206. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 207. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 208. SWITZERLAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 210. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 212. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 214. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. ASIA-PACIFIC ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 218. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 219. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 220. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 221. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 222. CHINA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 223. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 224. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 225. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 226. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 227. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 228. INDIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 229. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 230. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 231. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 232. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 233. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 234. JAPAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 235. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 236. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 237. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 238. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 239. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 240. AUSTRALIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 241. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 242. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 243. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 246. SOUTH KOREA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 247. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 248. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 249. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 250. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 251. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 252. INDONESIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 253. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 254. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 255. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 256. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 257. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 258. THAILAND ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 259. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 260. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 261. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 262. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 263. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 264. PHILIPPINES ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 265. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 266. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 267. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 268. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 269. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 270. MALAYSIA ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 271. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 272. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 273. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 274. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 275. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 276. SINGAPORE ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 277. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 278. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 279. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 280. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 281. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 282. VIETNAM ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 283. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2024 (USD MILLION)
TABLE 284. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2025-2030 (USD MILLION)
TABLE 285. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2018-2024 (USD MILLION)
TABLE 286. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY PURIFICATION, 2025-2030 (USD MILLION)
TABLE 287. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2024 (USD MILLION)
TABLE 288. TAIWAN ANTIBODIES CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2025-2030 (USD MILLION)
TABLE 289. ANTIBODIES CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 290. ANTIBODIES CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antibodies Contract Manufacturing market report include:
  • Lonza Group Ltd
  • Samsung Biologics Co., Ltd
  • WuXi Biologics (Hong Kong) Co., Ltd
  • Catalent, Inc.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Diosynth Biotechnologies US, LLC
  • Merck KGaA
  • AGC Biologics Inc
  • Thermo Fisher Scientific Inc.
  • Rentschler Biopharma SE

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 33.6 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Custom Polyclonal Antibody Production Service Market - Global Forecast 2025-2030 - Product Image

Custom Polyclonal Antibody Production Service Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Mammalian Polyclonal IgG Antibody Market - Global Forecast 2025-2030 - Product Image

Mammalian Polyclonal IgG Antibody Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Polyclonal Antibodies - Global Strategic Business Report - Product Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Antibodies Contract Manufacturing Market Size, Share & Trends Analysis Report, By Product (Monoclonal Antibodies, Polyclonal Antibodies, Others), By Source, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Antibodies Contract Manufacturing Market Size, Share & Trends Analysis Report, By Product (Monoclonal Antibodies, Polyclonal Antibodies, Others), By Source, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Geographical Regions and Key Players - Product Image

Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Geographical Regions and Key Players

  • Report
  • 391 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.